The global Ultomiris drug market is poised for significant expansion, with the market size projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, reflecting a strong compound annual growth rate (CAGR) of 14.4% during the forecast period. The market’s rapid growth is driven by the increasing prevalence of rare and life-threatening disorders,...
